Research On The International Entrepreneurship Strategy Of The Pharmaceutical Enterprisesin China

Medical and Pharmaceutical Industries has always been called "sunrise industry" which is very important that cares about the healths of human. There is a huge population in our country, and it is developing very quickly, so the demands of medicine are very huge. Integration of the world economy and financial crisis, pharmaceutical enterprises face the opportunity and challenge. Although pharmaceutical enterprises are increasingly developing with other enterprises from other countries, our enterprises have much gap from them. We should make innovation on building our infrastructure projects, medical infrastructure, good staff and management logos. How to use management method to enhance the R&D, and also enhance the competition, are the important and necessary ways.At the beginning of the paper, author analyzes the macro environment, domestic and international entrepreneurship, features and status of pharmaceutical enterprises. The problems and development are existing in our pharmaceutical enterprises, like low industry concentration, low R&D, hard to financing, small size of scale, serious pollution, development lags behind. It is increasingly developoing international pharmaceutical enterprises rapidly. Mergers and acquisitions are developing rapidly, and technological companies are becoming stronger and stronger. The outsourcings are increasingly growing, and the potential of biopharmaceutical is huge. The demands of medicine are growing up, and deepen the industrial division. The supervision and law of medicine are becoming strict, and the competition of patents are becoming more and more competitive.Jilin Province became the pharmaceutical gathering for its advantage of geographical conditions, resources and research strengths. It will be a long way that the Dongbao Pharmaceutical Co.,Ltd. develop international business. The paper analyzes Dongbao Pharmaceutical Co.,Ltd. international entrepreneurship strategy like the mode of the international development, overall strategy, innovation strategy, competitive strategy, merger and acquisition strategy, strategy alliance and global strategy. Dongbao Pharmaceutical Co.,Ltd. took the transverse mode of development, low-cost, growth strategy, and also had cooperation with other countries on cooperative construction and export. Now Dongbao Pharmaceutical Co.,Ltd. had became one of the largest three companies which can produce recombinant insulin, and it had intellectual property that can be proven by European Union.Based on SWOT analysis of Dongbao Pharmaceutical Co.,Ltd., the paper overview the advantages and disadvantages of the company. The Chinese pharmaceutical enterprises should enhance competitive, know the environment of the global, and solve the problems of development. Facing the global market, Chinese enterprises should maintain the advantages in order to grow rapidly, as well as intensify environmental protection, enhance the cooperation of R&D, improve the ability of its own, increase brand awareness, ensure quality and make a harmonious society.The paper is divided into six chapters. First, it is the theory parts. Secondly, it analyzes the Chinese pharmaceutical enterprises international entrepreneurship environment. Thirdly, it analyzes the status and characteristics of the global market. Last, based on the analysis of SWOT and strategy of successful enterprises, the expectation is brought forward for the further research.The first chapter is introduction which focuses on the background and significance of the research. It contains the basic content and the structural framework of the paper.The second chapter is the literature review of pharmaceutical international entrepreneurship. First of all, the paper make a literature review of international entrepreneurship, then research on the theory of the internationalization and then research on the strategic management. At last, the paper builds a model of international entrepreneurship strategy on pharmaceutical enterprises.The third chapter analyzes the environment of the domestic and international pharmaceutical enterprises. It contains the politic analysis, economic analysis, culture analysis and science and technology analysis.The forth chapter analyzes the status of the global pharmaceutical enterprises. Firstly, analyzes the development of the status and characteristics on Chinese pharmaceutical enterprises. Then from the data analyze the development of status and trends of the global pharmaceutical enterprises. At last, research on the problems of the pharmaceutical enterprises international entrepreneurship in China.The fifth chapter is the case study on the Jilin Province pharmaceutical enterprises international entrepreneurship strategy. The paper focus on the study of Dongbao Pharmaceutical Co.,Ltd. strategy, as well as the model of the international entrepreneurship strategy.The last chapter are summarizes and the expectation. It summarizes the Chinese pharmaceutical enterprises international entrepreneurship and then makes the development strategies.